Geriatric Patents (Class 426/800)
  • Patent number: 8652553
    Abstract: A method, device, and knife system for producing purëed, cooked foodstuffs from piece-form raw material. The method includes pre-chopping of the piece-form raw material in a pre-chopping unit, cooking of the pre-chopped raw material in a cooking plant, and final processing of the cooked product in a final-processing unit. Before cooking, the piece-form raw material is cut into small pieces by the pre-chopping unit such that a pumpable mass is produced from the piece-form raw material.
    Type: Grant
    Filed: August 19, 2011
    Date of Patent: February 18, 2014
    Assignee: Stephan Machinery GmbH
    Inventors: Dorothee Kloepping, Gerhard Brockmann, Henry Rose
  • Patent number: 8562952
    Abstract: Various embodiments of the invention disclosed herein include methods of inducing satiety a mammal in need thereof. Also disclosed are methods of inducing satiety in an obese mammal. Additionally disclose are method of suppressing appetite in a mammal in need thereof. Further disclosed are methods of treating obesity. The methods described herein involve the administration of serotonin, a serotonin agonist or a serotonin re-uptake inhibitor to the mammal.
    Type: Grant
    Filed: March 1, 2013
    Date of Patent: October 22, 2013
    Assignee: Cedars-Sinai Medical Center
    Inventor: Henry C. Lin
  • Patent number: 8388935
    Abstract: Disclosed is a method of treating small intestinal bacterial overgrowth (SIBO) or a SIBO-caused condition in a human subject. SIBO-caused conditions include irritable bowel syndrome, fibromyalgia, chronic pelvic pain syndrome, chronic fatigue syndrome, depression, impaired mentation, impaired memory, halitosis, tinnitus, sugar craving, autism, attention deficit/hyperactivity disorder, drug sensitivity, an autoimmune disease, and Crohn's disease. Also disclosed are a method of screening for the abnormally likely presence of SIBO in a human subject and a method of detecting SIBO in a human subject. A method of determining the relative severity of SIBO or a SIBO-caused condition in a human subject, in whom small intestinal bacterial overgrowth (SIBO) has been detected, is also disclosed.
    Type: Grant
    Filed: December 9, 2011
    Date of Patent: March 5, 2013
    Assignee: Cedars-Sinai Medical Center
    Inventors: Henry C. Lin, Mark Pimentel
  • Patent number: 8263147
    Abstract: Disclosed is a method of reducing the risk or severity of retinopathy of prematurity in preterm infants. The method comprises (a) measuring skin carotenoid levels in preterm infants, preferably by Raman Spectroscopy, and then (b) administering supplemental carotenoids to those infants in need thereof, wherein the supplemental carotenoids comprise lutein, lycopene, beta-carotene, and zeaxanthin. The supplemental carotenoids may be provided by an infant formula comprising, on a ready-to-feed basis, from about 100 to about 2000 mcg/liter of total carotenoids, wherein the total carotenoids include at least about 50 mcg/liter of lutein. The formulas may further comprise docosahexaenoic acid.
    Type: Grant
    Filed: March 8, 2011
    Date of Patent: September 11, 2012
    Assignee: Abbott Laboratories
    Inventors: Bridget Barrett-Reis, Pamela T. Price, Amy Mackey
  • Patent number: 8110177
    Abstract: Disclosed is a method of treating small intestinal bacterial overgrowth (SIBO) or a SIBO-caused condition in a human subject. SIBO-caused conditions include irritable bowel syndrome, fibromyalgia, chronic pelvic pain syndrome, chronic fatigue syndrome, depression, impaired mentation, impaired memory, halitosis, tinnitus, sugar craving, autism, attention deficit/hyperactivity disorder, drug sensitivity, an autoimmune disease, and Crohn's disease. Also disclosed are a method of screening for the abnormally likely presence of SIBO in a human subject and a method of detecting SIBO in a human subject. A method of determining the relative severity of SIBO or a SIBO-caused condition in a human subject, in whom small intestinal bacterial overgrowth (SIBO) has been detected, is also disclosed.
    Type: Grant
    Filed: April 27, 2010
    Date of Patent: February 7, 2012
    Assignee: Cedars-Sinai Medical Center
    Inventors: Henry C. Lin, Mark Pimentel
  • Patent number: 8097262
    Abstract: An enteral nutrient gel that is excellent at maintaining its solid matter (gel) form in the stomach, does not readily disintegrate or dissolve with a change in pH, is stable in its physical properties even during long-term storage, and can be passed through a feeding tube. The enteral nutrient gel contains agar, alginic acid and/or a salt thereof, soybean protein or a hydrolysate thereof, calcium, magnesium, dextrin, and, optionally, an oligosaccharide, a disaccharide and/or a monosaccharide. A solid composition containing 8 to 30 wt % protein, 2 to 25 wt % fats, and 40 to 70 wt % dextrin is used in preparing the enteral nutrient gel.
    Type: Grant
    Filed: August 31, 2007
    Date of Patent: January 17, 2012
    Assignee: En Otsuka Pharmaceutical Co., Ltd.
    Inventors: Minoru Kuribayashi, Yasunori Kogami
  • Patent number: 8067356
    Abstract: The present invention relates to a nutritional composition which is liquid and shelf-stable or powdered and reconstitutable. The composition has a fiber content of more than 2.5 g/fibber per 100 ml of the composition. Furthermore, it has an energy content of 1.3-1.8 kcal/ml. The composition is useful to improve and maintain gut comfort, restoring a well-balanced gut flora, especially in an elderly patient prone to malnutrition. The invention further relates to a process for preparing the nutritional composition.
    Type: Grant
    Filed: July 12, 2004
    Date of Patent: November 29, 2011
    Assignee: Nestec S.A.
    Inventors: Christina Ammann, Florence Rochat, Claudia Roessle
  • Patent number: 7829126
    Abstract: Disclosed are infant formulas and corresponding methods of using them to promote retinal health and vision development in infants. The formulas, which are free of egg phospholipids and comprise fat, protein, carbohydrate, vitamins, and minerals, including docosahexaenoic acid and, on a ready-to-feed basis, at least about 50 mcg/liter of lutein, wherein the weight ratio of lutein (mcg) to docosahexaenoic acid (mg) is from about 1:2 to about 10:1. The formulas are also believed to be especially useful in reducing the risk of retinopathy of prematurity in preterm infants.
    Type: Grant
    Filed: October 20, 2006
    Date of Patent: November 9, 2010
    Assignee: Abbott Laboratories
    Inventors: Bridget Barrett-Reis, Pamela T. Price, Amy Mackey
  • Patent number: 7824727
    Abstract: A novel food composition is provided in which omega-3 fatty acids, preferably including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), particularly in the form of fish oil, is provided in a liquid egg product.
    Type: Grant
    Filed: April 22, 2005
    Date of Patent: November 2, 2010
    Assignee: Burnbrae Farms Limited
    Inventors: Margaret F. Hudson, Phillip Lee Wing, Elyse Beauregard
  • Patent number: 7799365
    Abstract: A novel food composition is provided in which omega-3 fatty acids, preferably including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), particularly in the form of fish oil, is provided in a liquid egg product.
    Type: Grant
    Filed: March 12, 2002
    Date of Patent: September 21, 2010
    Assignee: BurnBrae Farms Limited
    Inventors: Margaret F. Hudson, Phillip Lee Wing, Elyse Beauregard
  • Patent number: 7790209
    Abstract: The invention provides a total enteral nutritious composition containing proteins, sugars, fats, minerals and vitamins, which improves serum albumin and ameliorates bedsores. The total enteral nutritious composition has a zinc/copper weight ratio of 10-25, and a zinc content of 1.5 mg or greater, a copper content of 0.075-0.15 mg, a sodium content of at least 185 mg, a vitamin B1 content of at least 0.30 mg, a vitamin B2 content of at least 0.25 mg and a protein content of at least 4.0 g, per 100 kcal of the composition. Preferably it has a protein content of at least 5.0 g, a vitamin B6 content of at least 0.30 mg, a biotin content of at least 1.0 ?g, a vitamin B12 content of at least 0.20 ?g, a folic acid content of at least 20 ?g, a ?-carotene content of at least 100 ?g and a vitamin C content of at least 10 mg. Medium-chain fatty acid oils preferably constitute 35% by weight of the fats of the fat source, per 100 kcal of the composition. The preferred composition viscosity is 6-18 mPa·s (25° C.
    Type: Grant
    Filed: March 22, 2007
    Date of Patent: September 7, 2010
    Assignee: Ajinomoto Co., Inc.
    Inventors: Toshihiro Ohmori, Naoki Hayashi, Kiyoshi Fujita, Hideki Tanaka, Kazunori Saima, Itaru Kon, Miki Tomoe
  • Patent number: 7736622
    Abstract: Disclosed is a method of treating small intestinal bacterial overgrowth (SIBO) or a SIBO-caused condition in a human subject. SIBO-caused conditions include irritable bowel syndrome, fibromyalgia, chronic pelvic pain syndrome, chronic fatigue syndrome, depression, impaired mentation, impaired memory, halitosis, tinnitus, sugar craving, autism, attention deficit/hyperactivity disorder, drug sensitivity, an autoimmune disease, and Crohn's disease. Also disclosed are a method of screening for the abnormally likely presence of SIBO in a human subject and a method of detecting SIBO in a human subject. A method of determining the relative severity of SIBO or a SIBO-caused condition in a human subject, in whom small intestinal bacterial overgrowth (SIBO) has been detected, is also disclosed.
    Type: Grant
    Filed: February 7, 2006
    Date of Patent: June 15, 2010
    Assignee: Cedars-Sinai Medical Center
    Inventors: Henry C. Lin, Mark Pimentel
  • Patent number: 7615207
    Abstract: Disclosed is a method of manipulating the rate of upper gastrointestinal transit of a substance in a mammal. Also disclosed are methods of manipulating satiety and post-prandial visceral blood flow. A method of treating visceral pain or visceral hypersensitivity in a human subject is also described. A method for prolonging the residence time of an orally or enterally administered substance by promoting its dissolution, bioavailability and/or absorption in the small intestine is also described. These methods are related to a method of transmitting to and replicating at a second location in the central nervous system a serotonergic neural signal originating at a first location in the proximal or distal gut of a mammal and/or a method of transmitting to and replicating at a second location in the upper gastrointestinal tract a serotonergic neural signal originating at a first location in the proximal or distal gut.
    Type: Grant
    Filed: February 9, 2007
    Date of Patent: November 10, 2009
    Assignee: Cedars-Sinai Medical Center
    Inventor: Henry C. Lin
  • Patent number: 7608245
    Abstract: Disclosed is a method of manipulating the rate of upper gastrointestinal transit of a substance in a mammal. Also disclosed are methods of manipulating satiety and post-prandial visceral blood flow. A method of treating visceral pain or visceral hypersensitivity in a human subject is also described. A method for prolonging the residence time of an orally or enterally administered substance by promoting its dissolution, bioavailability and/or absorption in the small intestine is also described. These methods are related to a method of transmitting to and replicating at a second location in the central nervous system a serotonergic neural signal originating at a first location in the proximal or distal gut of a mammal and/or a method of transmitting to and replicating at a second location in the upper gastrointestinal tract a serotonergic neural signal originating at a first location in the proximal or distal gut.
    Type: Grant
    Filed: July 13, 2006
    Date of Patent: October 27, 2009
    Assignee: Cedars-Sinai Medical Center
    Inventor: Henry C. Lin
  • Patent number: 7282223
    Abstract: This invention relates to a nutritional kit for use in preparing an individual for a predetermined activity which requires a clean digestive tract, particularly the colon. Such predetermined activities include, but are not limited to, gastrointestinal surgery and colon screenings. Specifically, the present invention provides an individual low amounts of fat, dietary fiber and solid food content to minimize stool formation and/or facilitate removal of stool from the digestive tract prior to the predetermined activity. The present invention also provides the individual with sufficient calories and nutrition to enable the individual to conduct daily, routine activities while utilizing the present invention.
    Type: Grant
    Filed: August 10, 2004
    Date of Patent: October 16, 2007
    Assignee: E-Z-EM, Inc.
    Inventor: Howard S. Stern
  • Patent number: 7244412
    Abstract: Disclosed is a method of manipulating the rate of upper gastrointestinal transit of a substance in a mammal. Also disclosed are methods of manipulating satiety and post-prandial visceral blood flow. A method of treating visceral pain or visceral hypersensitivity in a human subject is also described. A method for prolonging the residence time of an orally or enterally administered substance by promoting its dissolution, bioavailability and/or absorption in the small intestine is also described. These methods are related to a method of transmitting to and replicating at a second location in the central nervous system a serotonergic neural signal originating at a first location in the proximal or distal gut of a mammal and/or a method of transmitting to and replicating at a second location in the upper gastrointestinal tract a serotonergic neural signal originating at a first location in the proximal or distal gut.
    Type: Grant
    Filed: May 26, 2004
    Date of Patent: July 17, 2007
    Assignee: Cedars-Sinai Medical Center
    Inventor: Henry C. Lin
  • Patent number: 7223736
    Abstract: The present invention relates to methods and nutritional compositions for the prevention and treatment of cachexia and anorexia. The methods of the invention comprise administering a composition comprising effective amounts of ?-3 fatty acids such as alpha-linolenic acid, stearidonic acid, eicosapentaenoic acid, docosapentaenoic acid, docosahexaenoic acid or mixtures thereof; of branched-chain amino acids valine, leucine, isoleucine or mixtures thereof; with or without reduced levels of tryptophan and 5-hydroxytryptophan; and of antioxidant system selected from the group comprising beta-carotene, vitamin C, vitamin E, selenium, or mixtures thereof.
    Type: Grant
    Filed: February 23, 2004
    Date of Patent: May 29, 2007
    Assignee: Abbott Laboratories
    Inventors: Bonnie Chandler Abbruzzese, Mark Anthony McCamish, Frederick Oliver Cope, Stephen Joseph DeMichele
  • Patent number: 7081239
    Abstract: Disclosed is a method of manipulating the rate of upper gastrointestinal transit of a substance in a mammal. Also disclosed are methods of manipulating satiety and post-prandial visceral blood flow. A method of treating visceral pain or visceral hypersensitivity in a human subject is also described. A method for prolonging the residence time of an orally or enterally administered substance by promoting its dissolution, bioavailability and/or absorption in the small intestine is also described. These methods are related to a method of transmitting to and replicating at a second location in the central nervous system a serotonergic neural signal originating at a first location in the proximal or distal gut of a mammal and/or a method of transmitting to and replicating at a second location in the upper gastrointestinal tract a serotonergic neural signal originating at a first location in the proximal or distal gut.
    Type: Grant
    Filed: March 26, 2004
    Date of Patent: July 25, 2006
    Assignee: Cedars-Sinai Medical Center Burns and Allen Research Center
    Inventor: Henry C. Lin
  • Patent number: 7048906
    Abstract: Disclosed is a method of treating small intestinal bacterial overgrowth (SIBO) or a SIBO-caused condition in a human subject. SIBO-caused conditions include irritable bowel syndrome, fibromyalgia, chronic pelvic pain syndrome, chronic fatigue syndrome, depression, impaired mentation, impaired memory, halitosis, tinnitus, sugar craving, autism, attention deficit/hyperactivity disorder, drug sensitivity, an autoimmune disease, and Crohn's disease. Also disclosed are a method of screening for the abnormally likely presence of SIBO in a human subject and a method of detecting SIBO in a human subject. A method of determining the relative severity of SIBO or a SIBO-caused condition in a human subject, in whom small intestinal bacterial overgrowth (SIBO) has been detected, is also disclosed.
    Type: Grant
    Filed: April 17, 2001
    Date of Patent: May 23, 2006
    Assignee: Cedars-Sinai Medical Center
    Inventors: Henry C. Lin, Mark Pimentel
  • Patent number: 6921548
    Abstract: This invention relates to a process for manufacturing nutritionally balanced food compositions suitable for retort sterilization which have a low pH, extended shelf life, high antimicrobial activity, and which include protein in a stable emulsion. The primary protein source for the food composition is caseinates or milk protein concentrates and isolates comprised mostly of casein. The process includes two homogenization steps.
    Type: Grant
    Filed: July 12, 2002
    Date of Patent: July 26, 2005
    Assignee: Entra-Safe, Inc.
    Inventor: Clyde A. McCampbell
  • Patent number: 6811798
    Abstract: This invention relates to a soy protein product with a modified sugar profile. The soy protein product has desirable flavor and functional properties. The soy protein product has a high sucrose and monosaccharide content and is low in indigestible oligosaccharides. The soy protein product does not have galactinol that is present in soybeans developed to have a low indigestible oligosaccharide content. The soy protein product is rich in isoflavones. The method for manufacturing the soy protein product uses conventional soybeans that have better agronomic properties than soybeans developed to have a low indigestible oligosaccharide content. The method for manufacturing the soy protein product uses a &agr;-galactosidase enzyme. The method for manufacturing the soy protein product retains the natural level of isoflavones occurring in soybeans.
    Type: Grant
    Filed: November 18, 2003
    Date of Patent: November 2, 2004
    Assignee: Solae, LLC
    Inventor: Charles W. Monagle
  • Patent number: 6797309
    Abstract: This invention relates to a soy protein product with a modified sugar profile. The soy protein product has desirable flavor and functional properties. The soy protein product has a high sucrose and monosaccharide content and is low in indigestible oligosaccharides. The soy protein product does not have galactinol that is present in soybeans developed to have a low indigestible oligosaccharide content. The soy protein product is rich in isoflavones. The method for manufacturing the soy protein product uses conventional soybeans that have better agronomic properties than soybeans developed to have a low indigestible oligosaccharide content. The method for manufacturing the soy protein product uses a &agr;-galactosidase enzyme. The method for manufacturing the soy protein product retains the natural level of isoflavones occurring in soybeans.
    Type: Grant
    Filed: August 15, 2001
    Date of Patent: September 28, 2004
    Assignee: Solae, LLC
    Inventor: Charles W. Monagle
  • Patent number: 6676986
    Abstract: A method of making formed food products from food purees is disclosed. These products are ideal for use with children or adults who are unable to effectively chew their food due to age or illness. In this method, the food material is comminuted and mixed with relatively low levels of a lubricant/thickener and optionally flavoring or nutritional components (preferably after or while the food material is at a temperature of at least about 71° C.), transferred to a mold preferably in the shape of the original food product, and frozen. The food products made by this method are also disclosed.
    Type: Grant
    Filed: May 10, 2000
    Date of Patent: January 13, 2004
    Inventor: Samuel P. Huttenbauer, Jr.
  • Patent number: 6605310
    Abstract: The present invention provides a liquid oral supplement and a method for using the same. The supplement provides at least 2.25 calories per ml and provides at least 15% by caloric content of protein.
    Type: Grant
    Filed: June 6, 2001
    Date of Patent: August 12, 2003
    Assignee: Nestec S.A.
    Inventors: Eileen Fuchs, Chandrasekhara R. Mallangi, Peter Carhuff
  • Patent number: 6565891
    Abstract: A multinutrient nutritional supplement is provided that is designed to be most effective in optimizing health, increasing the immunity and decreasing the instances and severity of infection particularly among children.
    Type: Grant
    Filed: August 23, 2002
    Date of Patent: May 20, 2003
    Assignee: Tsar Health Private Ltd.
    Inventor: Ranjit Kumar Chandra
  • Patent number: 6562378
    Abstract: A multinutrient nutritional supplement is provided that is designed to be most effective in optimizing health, increasing the immunity and decreasing the instances and severity of infection particularly among adolescents.
    Type: Grant
    Filed: August 16, 2002
    Date of Patent: May 13, 2003
    Assignee: TSAR Health Private Ltd.
    Inventor: Renjit Kumar Chandra
  • Patent number: 6524610
    Abstract: A nutritional composition made from conventional food mixed on-site in a blender and treating patients with hepatic disorders.
    Type: Grant
    Filed: February 26, 2001
    Date of Patent: February 25, 2003
    Inventor: Julia Muszynska
  • Patent number: 6432457
    Abstract: The invention provides a confectionery bar containing a proteinaceous material and a carbohydrate material in a relative weight ratio higher than 1 (from 1:0 to about 1:0.999). The bar produced is very palatable and chewy and has good organoleptic properties. It may be coated (enrobed) or not as desired. The product of the invention provides a meal replacement for very low calorie diets, diet supplement or protein supplement, and may optionally comprise a carbohydrate material of low digestibility or indigestible nature.
    Type: Grant
    Filed: August 3, 2001
    Date of Patent: August 13, 2002
    Assignee: Bariatrix Products International, Inc.
    Inventor: Dennis Jones
  • Patent number: 6428832
    Abstract: The present invention relates to a process for the preparation of a polyunsaturated fatty acid (PUFA)-containing food, such as an infant formula, where a composition comprising a PUFA is added at a late stage of the infant formula preparation process in this way, the PUFA's are minimally exposed to conditions during the process that induce degradation of the PUFA's.
    Type: Grant
    Filed: March 18, 1997
    Date of Patent: August 6, 2002
    Assignee: DSM N.V.
    Inventors: Anthonius Cornelis Van Den Burg, Jan Willem Groenendaal
  • Patent number: 6423354
    Abstract: This invention relates to a low pH, nutritionally balanced food composition which has extended shelf life, high antimicrobial activity, and which includes casein proteins and a method manufacturing same.
    Type: Grant
    Filed: September 1, 2000
    Date of Patent: July 23, 2002
    Inventor: Woodrow C. Monte
  • Publication number: 20020068124
    Abstract: The object of the present invention is to provide a new healthy drink effectively utilizing azuki bean which is rich in mineral components and polyphenol components, and its production method. Washing a desired amount of azuki beans and extracting them under a certain heating condition to obtain an extracted liquid containing minerals and polyphenols from azuki bean, diluting the extracted liquid for adjusting concentration and filling it up in a closed container, heating and cooling the liquid in the closed container, followed by aging, to obtain a healthy drink containing sodium, calcium, magnesium, potassium, iron, tannin originated from azuki bean.
    Type: Application
    Filed: September 27, 2001
    Publication date: June 6, 2002
    Inventor: Kiyoji Endo
  • Patent number: 6387883
    Abstract: The present invention relates to methods and nutritional compositions for the prevention and treatment of cachexia and anorexia. The methods of the invention comprise administering a composition comprising effective amounts of &ohgr;-3 fatty acids such as alpha-linolenic acid, stearidonic acid, eicosapentaenoic acid, docosapentaenoic acid, docosahexaenoic acid or mixtures thereof; of branched-chain amino acids valine, leucine, isoleucine or mixtures thereof; with or without reduced levels of tryptophan and 5-hydroxytryptophan; and of antioxidant system selected from the group comprising beta-carotene, vitamin C, vitamin E, selenium, or mixtures thereof.
    Type: Grant
    Filed: August 18, 2000
    Date of Patent: May 14, 2002
    Assignee: Abbott Laboratories
    Inventors: Bonnie Chandler Abbruzzese, Mark Anthony McCamish, Frederick Oliver Cope, Stephen Joseph DeMichele
  • Patent number: 6326355
    Abstract: The present invention relates to methods and nutritional compositions for the prevention and treatment of cachexia and anorexia. The methods of the invention comprise administering a composition comprising effective amounts of &ohgr;-3 fatty acids such as alpha-linolenic acid, stearidonic acid, eicosapentaenoic acid, docosapentaenoic acid, docosahexaenoic acid or mixtures thereof, of branched-chain amino acids valine, leucine, isoleucine or mixtures thereof; with or without reduced levels of tryptophan and 5-hydroxytryptophan; and of antioxidant system selected from the group comprising beta-carotene, vitamin C, vitamin E, selenium, or mixtures thereof.
    Type: Grant
    Filed: January 7, 2000
    Date of Patent: December 4, 2001
    Assignee: Abbott Laboratories
    Inventors: Bonnie Chandler Abbruzzese, Mark Anthony McCamish, Frederick Oliver Cope, Stephen Joseph Demichele
  • Patent number: 6287623
    Abstract: Provided are a method for producing a protein-containing acidic food and drink that comprises processing a protein emulsion having a pH value that is higher than the isoelectric point of the protein in the emulsion at a high temperature to make the emulsion having a pH value that is lower than the isoelectric point of the protein; the protein-containing acidic food and drink produced in the method; protein-containing acidic food and drink containing protein, fat and oil, and water-soluble polysaccharide, in which the particles dispersed have a mean particle size of not greater than 15 &mgr;m; and a protein-containing acidic drink containing protein, fat and oil, and water-soluble polysaccharide, in which the particles dispersed have a mean particle size of not greater than 15 &mgr;m and/or having a viscosity not greater than 20 centipoises (cPs). The protein-containing acidic food and drink is smooth, tasteful, palatable and has good storage stability.
    Type: Grant
    Filed: November 4, 1998
    Date of Patent: September 11, 2001
    Assignee: Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Motokazu Nakayama, Ayako Muromachi, Shinpei Harada, Iwao Sato
  • Patent number: 6277426
    Abstract: A process for producing a whey product with extended shelf life, involving defatting the whey byproduct of cheesemaking, pasteurizing the defatted whey the first time, adding an adjuvant to the pasteurized whey, optionally adjusting the pH of the adjuvant-containing whey, pasteurizing the optionally pH-adjusted whey a second time, and recovering of the whey product.
    Type: Grant
    Filed: September 18, 1998
    Date of Patent: August 21, 2001
    Assignee: Swiss Alpine Power, Inc.
    Inventor: Hanspeter Reust
  • Patent number: 6248375
    Abstract: The present invention is directed to solid matrix nutritionals designed for the person with diabetes. The carbohydrate system of this invention utilizes a source of fructose in combination with at least one nonabsorbent carbohydrate to achieve the same effect of prior art complex multi-component carbohydrate systems. This carbohydrate system has the added benefits of tasting good and can be incorporated into solid matrix nutritionals. The solid matrix nutritionals may also include a source of dietary fiber and a source of indigestible oligosaccharides. The solid matrix nutritionals may be administered to a diabetic in the form of cereal, bread, cookies, muffins, bagels, biscuits, crackers and bars. Particularly, the present invention is directed to a nutritional bar designed for the person with diabetes which incorporates the carbohydrate system.
    Type: Grant
    Filed: March 14, 2000
    Date of Patent: June 19, 2001
    Assignee: Abbott Laboratories
    Inventors: Stephanie M. Gilles, Bryan W. Wolf, Bradley A. Zinker, Keith A. Garleb, Joseph E. Walton, Sue E. Nicholson
  • Patent number: 6245378
    Abstract: A nutritional supplement for facilitating the adaptation of skeletal muscle in individuals udergoing programs of strenuous exercise and counteracting defatigation and weariness in asthenic individuals is disclosed, which comprises a combination of L-camitine, acetyl L-camitine and propionyl L-carnitine as basic active ingredients. Optional ingredients comprise isovaleryl L-carnitine, branched-chained aminoacids and creatine and/or phosphocreatine.
    Type: Grant
    Filed: November 30, 1998
    Date of Patent: June 12, 2001
    Assignee: Sigma-Tau Healthscience S.p.A.
    Inventor: Claudio Cavazza
  • Patent number: 6200624
    Abstract: This invention is directed to the use of triglycerides containing fatty ester moieties that include arachidonic acid (AA) and docosahexaenoic acid (DHA) in enteral nutritionals or nutritional supplements. These triglycerides are derived from lipid mixtures which have high levels of sterols and phosphorous. A preferred embodiment of the invention comprises an infant or enteral nutritional, or nutritional supplement, that comprises a lipid source derived from egg yolk. The lipid source derived from egg yolk is prepared by transesterification or hydrolysis, subjecting the mixture to distillation, and esterification with glycerin to result in a triglyceride containing the desired fatty acids of AA and DHA and little or no sterols and phosphorus.
    Type: Grant
    Filed: January 26, 1996
    Date of Patent: March 13, 2001
    Assignee: Abbott Laboratories
    Inventors: Terrence Bruce Mazer, Robert Alan Miller, Charles Allan McCombs, Scott Donald Barnicki, James Cecil Phillips, Charles Edwan Sumner, Jr.
  • Patent number: 6117461
    Abstract: A food composition containing from about 80 to about 98 parts by weight of a first plant material derived from fruit and/or vegetable juices, from about 1 to about 10 parts by weight of a second plant material derived from fruit and/or vegetable fiber, and from about 1 to about 10 parts by weight of enzyme material selected from the group consisting of amylase, protease, lipase, cellulase, and mixtures thereof. Preferably, the first and second materials are each dried before being combined, and the enzyme material is derived from at least one species of Aspergillus mold.
    Type: Grant
    Filed: April 30, 1997
    Date of Patent: September 12, 2000
    Inventor: Humbart D. Santillo, Jr.
  • Patent number: 6077828
    Abstract: The present invention relates to methods and nutritional compositions for the prevention and treatment of cachexia and anorexia. The methods of the invention comprise administering a composition comprising effective amounts of .omega.-3 fatty acids such as alpha-linolenic acid, stearidonic acid, eicosapentaenoic acid, docosapentaenoic acid, docosahexaenoic acid or mixtures thereof; of branched-chain amino acids valine, leucine, isoleucine or mixtures thereof; with or without reduced levels of tryptophan and 5-hydroxytryptophan; and of antioxidant system selected from the group comprising beta-carotene, vitamin C, vitamin E, selenium, or mixtures thereof.
    Type: Grant
    Filed: April 24, 1997
    Date of Patent: June 20, 2000
    Assignee: Abbott Laboratories
    Inventors: Bonnie Chandler Abbruzzese, Mark Anthony McCamish, Frederick Oliver Cope, Stephen Joseph Demichele
  • Patent number: 6042854
    Abstract: Liquid, nutritionally complete formulas are disclosed with improved physical stability. The nutritionally complete formulas are pourable, yet are able to hold minerals, insoluble fiber and flavoring agents such as cocoa powder in suspension without the formation of a sediment that is not readily redispersible. The invention comprises the use of gellan gum at a concentration of between 10-500 parts per million. Although gellan gum alone is sufficient, the nutritionally complete formula may also comprise other stabilizers such as carrageenan and/or carboxymethylcellulose.
    Type: Grant
    Filed: February 8, 1999
    Date of Patent: March 28, 2000
    Assignee: Abbott Laboratories
    Inventors: Jeffrey G. Morris, Normanella T. DeWille, Gregory A. Snowden, Michael A. Chandler, Amanda L. Gunn, Rohini P. Mulchandani, Steven L. Hartline
  • Patent number: 6036984
    Abstract: A complete, nutritionally balanced coffee drink providing caloric and protein nutritional support for patients, particularly elderly and long-term care patients is provided. An instant coffee composition, a method for making the instant coffee composition and coffee drink made therefrom are described. The composition and drink has a caloric distribution including from about 16% to 30% of a protein component, from about 40% to 60% of a carbohydrate component and from about 15% to 33% of a lipid component. The instant coffee composition readily dissolves in hot water to provide a beverage which looks and tastes like black coffee which may be administered to a patient in need of nutritional support.
    Type: Grant
    Filed: December 2, 1998
    Date of Patent: March 14, 2000
    Assignee: Nestec Ltd.
    Inventors: Claude Sartorio, Paul Lin, Joseph Burri, Olaf Wehrspann, Shen-Youn Chang
  • Patent number: 5972415
    Abstract: Nutritive composition based on fibers comprising at least a mixture of pea internal fibers, pea external envelope fibers and inulin.
    Type: Grant
    Filed: May 28, 1998
    Date of Patent: October 26, 1999
    Assignee: Nestec S.A.
    Inventors: Dominique Brassart, Veronique Jaussan, Thomas Schweizer, Thierry Brun
  • Patent number: 5972393
    Abstract: A dehydrated acidified milk product is made by preparing an aqueous composition containing milk protein and having a dry matter content of from 10% to 40% by weight. The aqueous composition is inoculated with a strain of L. helveticus which exclusively forms lactic acid L(+) and a strain of S. thermophilus and fermented to obtain a fermented composition having a pH of from 4 to 5. The fermented composition is dried to obtain the dehydrated acidified product.
    Type: Grant
    Filed: October 23, 1992
    Date of Patent: October 26, 1999
    Assignee: Nectec S.A.
    Inventors: Ernst Beutler, Leuka Favre-Galliand, Johann Illi, Andreas Sutter
  • Patent number: 5962062
    Abstract: A milk having a formulated lipid composition wherein the lipids are lipids of lactic and vegetable origin which are, by weight, (i) from 30% to 40% milk fat lipids, (ii) from 30% to 40% of a first oil substance which have an oleic acid content in an amount greater than 60%, and (iii) from 1% to 30% of oil substance which provide n-3 and n-6 polyunsaturated fatty acids and so that triglyceride fatty acids of the lipids comprise 20% to 40% saturated fatty acids of lactic origin, 35% to 60% monounsaturated fatty acids, and 15% to 30% of n-3 and n-6 polyunsaturated in a ratio of n-6 to n-3 fatty acids of from 5:1 to 10:1.
    Type: Grant
    Filed: June 27, 1997
    Date of Patent: October 5, 1999
    Assignee: Nestec S.A.
    Inventors: Anne-Lise Carrie, Edward Fern, Mathilde Fleith, Armand Malnoe, Martin Vikas
  • Patent number: 5932259
    Abstract: A bone reinforcing agent comprising a basic protein fraction or a basic peptide fraction derived from milk as an effective component is described. The basic protein fraction is obtained by passing milk or a raw material derived from milk over a cation exchange resin and eluting the adhered fraction. The basic peptide fraction is obtained by hydrolyzing the basic protein fraction with a protease. The basic protein fraction and basic peptide fraction of the present invention promote the growth of osteoclasts and suppress the resorption of osteoclasts, and thereby strengthening bone when administered orally. The invention is useful for treating or preventing bone diseases such as osteoporosis.
    Type: Grant
    Filed: September 22, 1995
    Date of Patent: August 3, 1999
    Inventors: Ken Kato, Hiroaki Matsuyama, Yukihiro Takada, Toshiaki Uchida, Seiichiro Aoe
  • Patent number: 5928690
    Abstract: The use of proteolytic enzymes and heat gelling gums or sodium alginate and/or starches to manufacture pureed meat and/or poultry products from raw meat and/or poultry. The proteolytic enzyme is used to digest the meat and/or poultry proteins upon heating. This gives the cooked product its desired pureed texture. The heat gelling gum or sodium alginate and/or starch is added to the product formulation to bind the digested proteins into the appropriate shape and/or to tie up water.
    Type: Grant
    Filed: October 28, 1997
    Date of Patent: July 27, 1999
    Assignee: Hudson Foods, Inc.
    Inventor: William R. Wiebe, Jr.
  • Patent number: 5929109
    Abstract: The present invention relates to an agent for enhancing and stabilizing the activity of Bifidus factor, containing at least one member selected from the group consisting of ascorbic acid, hyposulfurous acid and acetic anhydride as the effective ingredient, and by preparing the agent singly or in combination with Bifidus factor as a food and drink type or as a composition of pharmaceutical type, intestinal microflora can be ameliorated. The agent can be used as a selective medium for assaying the number of bifidobacteria.
    Type: Grant
    Filed: October 3, 1997
    Date of Patent: July 27, 1999
    Assignee: Meiji Milk Products Company Limited
    Inventors: Hiroharu Mori, Kakuhei Isawa, Tsutomu Kaneko
  • Patent number: 5904948
    Abstract: A complete, nutritionally balanced coffee drink providing caloric and protein nutritional support for patients, particularly elderly and long-term care patients is provided. An instant coffee composition, a method for making the instant coffee composition and coffee drink made therefrom are described. The composition and drink has a caloric distribution including from about 16% to 30% of a protein component, from about 40% to 60% of a carbohydrate component and from about 15% to 33% of a lipid component. The instant coffee composition readily dissolves in hot water to provide a beverage which looks and tastes like black coffee which may be administered to a patient in need of nutritional support.
    Type: Grant
    Filed: March 12, 1997
    Date of Patent: May 18, 1999
    Assignee: Nestec Ltd.
    Inventors: Claude Sartorio, Paul Lin, Joseph Burri, Olaf Wehrspann, Shen-Youn Chang
  • Patent number: 5869118
    Abstract: Liquid, nutritionally complete formulas are disclosed with improved physical stability. The nutritionally complete formulas are pourable, yet are able to hold minerals, insoluble fiber and flavoring agents such as cocoa powder in suspension without the formation of a sediment that is not readily redispersible. The invention comprises the use of gellan gum at a concentration of between 10-500 parts per million. Although gellan gum alone is sufficient, the nutritionally complete formula may also comprise other stabilizers such as carrageenan and/or carboxymethylcellulose.
    Type: Grant
    Filed: November 13, 1996
    Date of Patent: February 9, 1999
    Assignee: Abbott Laboratories
    Inventors: Jeffrey G. Morris, Normanella T. Dewille, Gregory A. Snowden, Michael A. Chandler, Amanda L. Gunn, Rohini P. Mulchandani, Steven L. Hartline